Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mette Opstrup Abildgaard"'
Autor:
Mette Opstrup Abildgaard, Søren Høyer, Torben F. Ørntoft, Siri H. Strand, Chris Parker, Benedicte Parm Ulhøi, Christa Haldrup, Helle Kristensen, Karina Dalsgaard Sørensen, Michael Borre
Publikováno v:
Sørensen, K D, Abildgaard, M O, Haldrup, C, Ulhøi, B P, Kristensen, H, Strand, S H, Parker, C, Høyer, S, Borre, M & Ørntoft, T F 2013, ' Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer ', B J C, no. 108, pp. 420-428 . https://doi.org/10.1038/bjc.2012.549
British Journal of Cancer
British Journal of Cancer
Background:Novel biomarkers for prostate cancer (PC) are urgently needed. This study investigates the expression, epigenetic regulation, and prognostic potential of ANPEP in PC.Methods:Aminopeptidase N (APN; encoded by ANPEP) expression was analysed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5763dcde932fc176d1edb0a4f7e5fa31
https://pure.au.dk/portal/da/publications/prognostic-significance-of-aberrantly-silenced-anpep-expression-in-prostate-cancer(d684c7b2-e3e7-4bc0-b6b0-432d0eb1e087).html
https://pure.au.dk/portal/da/publications/prognostic-significance-of-aberrantly-silenced-anpep-expression-in-prostate-cancer(d684c7b2-e3e7-4bc0-b6b0-432d0eb1e087).html
Autor:
Martin Mørck Mortensen, Helle Kristensen, Karina Dalsgaard Sørensen, Niels Tørring, Michael Borre, Peter D. Ottosen, Mette Opstrup Abildgaard, Peter J. Wild, Lars Dyrskjøt, Francisco Mansilla, Torben F. Ørntoft, Benedicte Parm Ulhøi
Publikováno v:
International journal of cancer. 130(4)
This study investigates the expression and biomarker potential of zinc finger protein 132 (ZNF132) in prostate cancer (PC) by transcriptional profiling and immunohistochemical analysis of tissue microarrays, including tumor specimens from 615 radical
Autor:
Mette Opstrup Abildgaard, Helle Kristensen, Søren Høyer, Chris Parker, Karina Dalsgaard Sørensen, Christa Haldrup, Benedicte Parm Ulhøi, Torben F. Ørntoft, Michael Borre, Siri H. Strand
Publikováno v:
Cancer Research. 72:3636-3636
Prostate cancer (PC) is a common malignancy and a leading cause of cancer-associated mortality among males in Western countries. Novel diagnostic and prognostic biomarkers for PC are urgently needed to prevent overdiagnosis and overtreatment of nonag